DXM + MXE and other ketamine analogues

Group assessment

This PHI covers the named group; its members do not have separate PHI ratings.

PHI 4 to 7

https://dxm-atlas.org/en/interactions/mxe-ketamine-analogues/

Compare

Key points for this combination

Heterogeneous group. Additional monoamine effects possible for some compounds

General concepts in this text

Monoamines

A group of substances formed in living organisms; several act as chemical messengers between nerve cells.

Examples include serotonin, dopamine and norepinephrine.

Sources: Monoamines

How well is this understood?

Mechanism confidence: medium

Confidence in the mechanism: medium

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Confidence in human DXM data: low

Confidence in direct human evidence involving DXM: low

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method

How to read ratings and study limits

How do the substances interact?

How can the effects add up?

Mechanism: NMDA — Overlapping NMDA-antagonist effects
ⓘ

NMDA receptor

A glutamate receptor that controls an ion channel in a cell.

An ion channel lets electrically charged particles pass.

Sources: NMDA receptor
Mechanism: MONO — Additional monoamine effects (uncertain contribution)
ⓘ

Variable additional monoamine effects within a heterogeneous group

Sources

Check the review’s wording

Heterogeneous group; additional monoamine effects possible for some compounds

Combination row in the review: NMDA — Overlapping NMDA-antagonist effects; MONO — Additional monoamine effects? (uncertain contribution)

Related entries

Reference

Open the source and related combinations →